Jardiance is propping up Boehringer’s balance sheets, generating annual sales of more than $2 billion for the German pharma last year, up 52.5% compared with 2017.
Eli Lilly and Boehringer Ingelheim’s longstanding alliance in diabetes has delivered another new product, this time a three-drug combination – Trijardy XR – that extends their blockbuster ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback